Financial Performance - The company's operating revenue for Q1 2024 was CNY 30,487.45 million, a decrease of 38.35% compared to the same period last year[3] - The net profit attributable to shareholders was CNY 1,149.69 million, down 72.14% year-on-year[3] - The net profit after deducting non-recurring gains and losses was CNY 823.77 million, a decline of 79.72% compared to the previous year[3] - The basic earnings per share were CNY 0.09, reflecting a decrease of 71.88% year-on-year[3] - Total operating revenue for Q1 2024 was ¥304,874,534.07, a decrease of 38.4% compared to ¥494,523,598.30 in Q1 2023[17] - Net profit for Q1 2024 was ¥11,496,246.93, a decline of 72.2% from ¥41,259,946.58 in Q1 2023[18] - Basic and diluted earnings per share for Q1 2024 were both ¥0.09, compared to ¥0.32 in Q1 2023[19] - The company reported a total comprehensive income of ¥10,819,184.22 for Q1 2024, significantly lower than ¥40,854,418.90 in Q1 2023[19] Research and Development - Research and development expenses totaled CNY 1,145.69 million, a decrease of 15.40%, while the R&D expenditure accounted for 3.76% of operating revenue, an increase of 1.02 percentage points[3] - Research and development expenses for Q1 2024 were ¥11,456,856.40, a decrease of 15.4% from ¥13,542,325.31 in Q1 2023[17] Assets and Liabilities - The total assets at the end of the reporting period were CNY 158,249.16 million, an increase of 3.26% from the end of the previous year[4] - The total assets as of March 31, 2024, amounted to CNY 1,582,491,607.42, an increase from CNY 1,532,485,236.08 as of December 31, 2023, reflecting a growth of approximately 3.3%[13] - The company's total liabilities increased to CNY 568,295,891.91 from CNY 538,058,061.81, which is an increase of about 5.6%[15] - The total current liabilities rose to CNY 421,951,637.99 from CNY 374,461,211.06, indicating an increase of around 12.7%[15] - The total equity as of March 31, 2024, was CNY 1,014,195,715.51, up from CNY 994,427,174.27, reflecting a growth of approximately 2.7%[15] Cash Flow - The company reported a net cash flow from operating activities of CNY -4,475.64 million, which is not applicable for year-on-year comparison[3] - Cash flow from operating activities in Q1 2024 was negative at -¥44,756,363.92, an improvement from -¥112,997,488.09 in Q1 2023[21] - The net cash flow from investing activities was -$93,848,959.71, compared to -$44,846,248.00 in the previous period[22] - The net cash flow from financing activities was $35,460,151.11, a significant improvement from -$1,505,037.49 in the prior year[22] - The net increase in cash and cash equivalents for the quarter was -$103,130,399.45, compared to -$159,353,501.73 in the same quarter last year[22] Market and Product Development - The company has not disclosed any new product or technology developments in this report[12] - There are no significant changes in the shareholder structure or any new strategies mentioned for market expansion or mergers and acquisitions[12] - The company did not report any new product launches or significant market expansion strategies during this quarter[20] Other Financial Metrics - The company received government subsidies amounting to CNY 363.26 million, which were included in non-recurring gains and losses[5] - The sales volume of homogeneous precious metal catalysts decreased by 15.92% year-on-year, contributing to the decline in net profit[6] - The revenue from the basic chemical sector increased to 19.02% of total revenue, indicating a gradual release of its positive impact on income and profit[6] - Other comprehensive income after tax for Q1 2024 was -¥677,062.71, compared to -¥405,527.68 in Q1 2023[19] - The company raised $9,000,000.00 from investments and $44,600,000.00 from borrowings during the quarter[22] - The total cash inflow from financing activities was $53,600,000.00, while cash outflow was $18,139,848.89[22] - The impact of exchange rate changes on cash and cash equivalents was $14,773.07, compared to -$4,728.15 in the previous period[22]
凯立新材(688269) - 2024 Q1 - 季度财报